These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 21055616

  • 1. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers.
    Kilbourn MR.
    Nucl Med Biol; 2010 Nov; 37(8):869-71. PubMed ID: 21055616
    [Abstract] [Full Text] [Related]

  • 2. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.
    Fagerholm V, Mikkola KK, Ishizu T, Arponen E, Kauhanen S, Någren K, Solin O, Nuutila P, Haaparanta M.
    J Nucl Med; 2010 Sep; 51(9):1439-46. PubMed ID: 20720057
    [Abstract] [Full Text] [Related]

  • 3. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF.
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [Abstract] [Full Text] [Related]

  • 4. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR, Sherman PS, Kuszpit K.
    Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424
    [Abstract] [Full Text] [Related]

  • 5. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR.
    J Cereb Blood Flow Metab; 1999 Dec 01; 19(12):1376-84. PubMed ID: 10598942
    [Abstract] [Full Text] [Related]

  • 6. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
    Tong J, Wilson AA, Boileau I, Houle S, Kish SJ.
    Synapse; 2008 Nov 01; 62(11):873-6. PubMed ID: 18720517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1997 Sep 01; 17(9):919-31. PubMed ID: 9307605
    [Abstract] [Full Text] [Related]

  • 9. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats.
    Tsao HH, Lin KJ, Juang JH, Skovronsky DM, Yen TC, Wey SP, Kung MP.
    Nucl Med Biol; 2010 May 01; 37(4):413-9. PubMed ID: 20447551
    [Abstract] [Full Text] [Related]

  • 10. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF.
    J Nucl Med; 2008 Jul 01; 49(7):1171-6. PubMed ID: 18552132
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    Zheng P, Lieberman BP, Choi SR, Plöessl K, Kung HF.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3435-8. PubMed ID: 21531556
    [Abstract] [Full Text] [Related]

  • 13. Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent.
    Liu F, Choi SR, Zha Z, Ploessl K, Zhu L, Kung HF.
    Nucl Med Biol; 2018 Feb 01; 57():42-49. PubMed ID: 29306111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [18F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes.
    Naganawa M, Lim K, Nabulsi NB, Lin SF, Labaree D, Ropchan J, Herold KC, Huang Y, Harris P, Ichise M, Cline GW, Carson RE.
    Mol Imaging Biol; 2018 Oct 01; 20(5):835-845. PubMed ID: 29468404
    [Abstract] [Full Text] [Related]

  • 16. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR, Tsai CL, Huang YY, Shiue CY, Tzen KY, Yen RF, Hsin LW.
    PLoS One; 2016 Oct 01; 11(9):e0161295. PubMed ID: 27612194
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M.
    Nucl Med Biol; 2008 Nov 01; 35(8):825-37. PubMed ID: 19026944
    [Abstract] [Full Text] [Related]

  • 19. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1996 Nov 01; 16(6):1288-99. PubMed ID: 8898703
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
    Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP, Kung HF.
    Nucl Med Biol; 2007 Apr 01; 34(3):233-7. PubMed ID: 17383572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.